Semaglutide is available as Wegovy and Ozempic injections, and also as Rybelsus tablets. The study's findings indicate a potential link between these medications and a lower risk of dementia.

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...

A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight loss drugs Ozempic and Wegovy who say ... the “devastating” risk, which left them ...

Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists, could significantly reduce the risk of developing any type of dementia, according to a meta-analysis of 26 ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...

such as heart disease risk and sleep apnea. In a release Wednesday, Novo Nordisk said the FDA could make a decision on whether to approve Wegovy for MASH as early as the end of the year.

Novo Nordisk's Wegovy, a weight loss drug ... Available as a 2.4 mg injectable, this drug reduces the risk of major cardiovascular events such as death, heart attack, or stroke in adults with ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to new research. The disease, known as metabolic dysfunction-associated ...

They said that semaglutide, which is sold under the brand names Ozempic and Wegovy, was “statistically significantly associated with a decreased risk” of dementia. Semaglutide was initially ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...